Anticancer Drug Metabolism: Chemotherapy Resistance and New Therapeutic Approaches

QR Code

Anticancer Drug Metabolism: Chemotherapy Resistance and New Therapeutic Approaches

None

Saved in:

Bibliographic Details
Main Authors:	Akhdar, Hanane, Legendre, Claire, Aninat, Caroline, More, Fabrice
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/29245
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Section VI. NEW APPROACHES TO ANTICANCER DRUG DEVELOPMENT
Published: (2016-12-01)

Cardiotoxicity of Anticancer Drugs
by: I. Maiborodin, et al.
Published: (2025-02-01)

Taurine-Based Hybrid Drugs as Potential Anticancer Therapeutic Agents: In Vitro, In Vivo Evaluations
by: Saltanat Nakypova, et al.
Published: (2025-07-01)

Circular RNAs as Targets for Developing Anticancer Therapeutics
by: Jaewhoon Jeoung, et al.
Published: (2025-07-01)

Mechanisms of drug resistance to neoadjuvant chemotherapy in breast cancer
by: K. A. Aliev, et al.
Published: (2024-10-01)

Atrial Fibrillation Associated with Anticancer Drugs
by: O. D. Ostroumova, et al.
Published: (2020-12-01)

Therapeutic Approach to Focal and Segmental Glomerulosclerosis (FSGS) Recurrence in Kidney Transplant Recipients
by: Canaud, Guillaume, et al.
Published: (2011)

Continuous ultraviolet irradiation induces the development of irreversible resistance of melanoma cells to anticancer drugs
by: Yu. Yu. Shchegolev, et al.
Published: (2023-10-01)

Failure of Pancreatic Cancer Chemotherapy: Consequences of Drug Resistance Mechanisms
by: Bhardwaj, Vikas, et al.
Published: (2012)

Drug design of an anticancer drug: QSAR modeling, and molecular docking
by: Sedigheh Aghayari
Published: (2025-09-01)

The study of new anticancer drug delivery system based on the boron nitride nanoparticles
by: I. Yu. Zhitnyak, et al.
Published: (2016-06-01)

Hypoxic state and glycolysis as a possible anticancer therapeutic target
by: V. A. Koblyakov
Published: (2015-06-01)

Negative Impact of Paclitaxel Crystallization on Hydrogels and Novel Approaches for Anticancer Drug Delivery Systems
by: Castro, Javier S., et al.
Published: (2011)

Drug-Resistant Cholangiocarcinoma Cell Lines for Therapeutic Evaluation of Novel Drugs
by: Kevin Delgado-Calvo, et al.
Published: (2025-07-01)

Cell Cycle Regulatory Proteins in Breast Cancer: Molecular Determinants of Drug Resistance and Targets for Anticancer Therapies
by: Ahmad, Aamir, et al.
Published: (2012)

Safety of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2024-04-01)

Efficacy of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2023-07-01)

Topical Administration of Anticancer Drugs for Skin Cancer Treatment
by: Taveira, Stephânia Fleury, et al.
Published: (2011)

Ferrocene-Based Hybrid Drugs as Potential Anticancer and Antibacterial Therapeutic Agents for Incorporation into Nanocarriers: In Silico, In Vitro, Molecular Docking Evaluations
by: Sijongesonke Peter, et al.
Published: (2025-05-01)

Computational Virtual Screening Towards Designing Novel Anticancer Drugs
by: Chen, Po-Yuan
Published: (2012)

Potential of primary drug prevention of cardiotoxicity in the context of anticancer therapy
by: Yu. A. Vasyuk, et al.
Published: (2023-01-01)

Significance, Mechanisms, and Progress of Anticancer Drugs Targeting HGF-Met
by: Sakai, Katsuya, et al.
Published: (2011)

INDUCTION OF ANTICANCER RESISTANCE IN MICE TREATED WITH LECTIN OF BACTERIAL ORIGIN
by: О. А. Танасієнко, et al.
Published: (2010-06-01)

Cardiotoxicity of anticancer drugs and radiotherapy in patients with hematologic malignancies and solid tumors
by: L. M. Kogoniya, et al.
Published: (2022-07-01)

DENDRIMERS IN ANTICANCER TARGETED DRUG DELIVERY: ACCOMPLISHMENTS, CHALLENGES AND DIRECTIONS FOR FUTURE
by: A. M. Amjad
Published: (2021-06-01)

Emerging Trends in the Application of Nanosuspension-Based Biomaterials for Anticancer Drug Delivery
by: Aldeeb MME, et al.
Published: (2025-07-01)

Potential therapeutic implications of miRNAs in osteosarcoma chemotherapy
by: Dan Chen, et al.
Published: (2017-09-01)

Long-term results of chemotherapy of tuberculosis with a widespread drug-resistant pathogen using bedaquiline
by: A. Yu. Chernikov, et al.
Published: (2023-04-01)

Role of Histone Deacetylases in Drug-Resistant Melanoma: Mechanisms and Therapeutic Implications
by: Bhuvanesh Sukhlal Kalal
Published: (2025-04-01)

Approaches to anticancer therapy based on modulation of DNA methylation
by: V. P. Maksimova, et al.
Published: (2024-09-01)

Therapeutic resistance training: proposal for an algorithm-based approach
by: Weber Frank, et al.
Published: (2024-03-01)

Chemotherapy and Mechanisms of Resistance in Breast Cancer
by: Oliveira, Andre Lima de, et al.
Published: (2012)

Prenylated Chalcones as Anticancer Agents Against Castration-Resistant Prostate Cancer
by: Marcos Morales-Reyna, et al.
Published: (2025-06-01)

EPIGENETIC EFFECTS OF ENZASTAURIN – A NEW ASPECT IN THE MECHANISM OF ACTION OF AN ANTICANCER DRUG FROM PROTEIN KINASE INHIBITORS
by: V. P. Maksimova, et al.
Published: (2020-09-01)

Utilization and Determinants of Anticancer Drugs Under China&rsquo;s National Drug Price Negotiation Policy
by: Tuo B, et al.
Published: (2025-07-01)

Short-chain fatty acids (SCFAs) in gut health: Implications for drug metabolism and therapeutics
by: P. Sankarganesh, et al.
Published: (2025-09-01)

Interaction of Alkylphospholipid Formulations with Breast Cancer Cells in the Context of Anticancer Drug Development
by: Koklic, Tilen, et al.
Published: (2011)

Microfaradaic Electrochemical Biosensors for the Study of Anticancer Action of DNA Intercalating Drug: Epirubicin
by: Pitre, Krishna, et al.
Published: (2011)

Pharmacogenomics in pediatric oncology: possibility to overcome drug-induced toxicity of anticancer treatment
by: Yu. V. Dinikina, et al.
Published: (2024-01-01)

Tumor Niche Influences the Activity and Delivery of Anticancer Drugs: Pharmacology Meets Chemistry
by: Mauro Ravera, et al.
Published: (2025-07-01)